Stockscreener 앱 받기
8.185
6.46%
-0.565
전일 마감가:
$8.75
열려 있는:
$8.4901
하루 거래량:
51,813
Relative Volume:
0.44
시가총액:
$55.51M
수익:
-
순이익/손실:
$-75.08M
주가수익비율:
-0.7184
EPS:
-11.3931
순현금흐름:
$-40.10M
1주 성능:
-7.72%
1개월 성능:
+2.44%
6개월 성능:
-66.04%
1년 성능:
-57.06%
1일 변동 폭
$8.01
$8.6075
1주일 범위
$8.01
$9.2713
52주 변동 폭
$5.67
$42.79
인스틸 바이오 Stock (TIL) Company Profile
명칭
Instil Bio Inc
전화
(972) 499-3350
주소
3963 MAPLE AVENUE, DALLAS
Compare TIL vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TIL
Instil Bio Inc
|
8.185 | 59.34M | 0 | -75.08M | -40.10M | -11.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.91 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
743.35 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
702.44 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.93 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
283.74 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
인스틸 바이오 Stock (TIL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-07 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2026-01-06 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-01-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-11-04 | 개시 | JMP Securities | Mkt Perform |
| 2024-04-12 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-11-01 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2022-11-01 | 다운그레이드 | Truist | Buy → Hold |
| 2021-08-13 | 개시 | Robert W. Baird | Outperform |
| 2021-04-13 | 개시 | Cowen | Outperform |
| 2021-04-13 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-04-13 | 개시 | Truist | Buy |
모두보기
인스틸 바이오 주식(TIL)의 최신 뉴스
Precision Trading with Instil Bio Inc. (TIL) Risk Zones - Stock Traders Daily
TIL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Technical Reactions to TIL Trends in Macro Strategies - Stock Traders Daily
Instil Bio Inc expected to post a loss of $2.03 a shareEarnings Preview - TradingView
Does Instil Bio Inc. meet Warren Buffett’s criteriaEarnings Growth Report & Weekly Setup with ROI Potential - mfd.ru
Trading the Move, Not the Narrative: (TIL) Edition - Stock Traders Daily
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc.TIL - PR Newswire
Technical Analysis: Does Instil Bio Inc. meet Warren Buffett’s criteriaQuarterly Earnings Report & Growth Focused Investment Plans - mfd.ru
Market Leaders: Is Instil Bio Inc gaining market shareBreakout Watch & Advanced Technical Signal Analysis - baoquankhu1.vn
(TIL) Volatility Zones as Tactical Triggers - Stock Traders Daily
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, ... - Bluefield Daily Telegraph
TIL Should I Buy - Intellectia AI
Price-Driven Insight from (TIL) for Rule-Based Strategy - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Encourages Instil Bio, Inc. (TIL) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Instil Bio, Inc. (TIL) And Encourages Shareholders to Connect - accessnewswire.com
Entry Recap: Is TROOPS Inc benefiting from interest rate changesJuly 2025 Opening Moves & Target Return Focused Stock Picks - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Instil Bio, Inc. (TIL) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
TIL ALERT: Ongoing Investigation Into Instil Bio, Inc.Contact Levi & Korsinsky - TMX Newsfile
Instil Bio Faces Investigation After AXN-2510 Discontinuation, Stock Plummets 45.81% - intellectia.ai
Bronstein, Gewirtz & Grossman, LLC Encourages Instil Bio, Inc. (TIL) Stockholders to Inquire about Securities Investigation - accessnewswire.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Instil Bio, Inc. (TIL) and Encourages Investors to Learn More About the Investigation - accessnewswire.com
(TIL) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Is Investigating Instil Bio, Inc. (TIL) And Encourages Investors to Connect - accessnewswire.com
Forecast Cut: Can Instil Bio Inc scale operations efficientlyJuly 2025 Closing Moves & Technical Buy Zone Confirmations - baoquankhu1.vn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AST SpaceMobile, Inc. - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Instil Bio, Inc. (TIL) And Encourages Stockholders to Reach Out - accessnewswire.com
Published on: 2026-01-13 02:54:06 - ulpravda.ru
Instil Bio, Inc. (TIL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - accessnewswire.com
Will Instil Bio Inc. stock see PE expansionJuly 2025 Drop Watch & Fast Entry Momentum Alerts - Улправда
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Instil Bio, Inc. (TIL) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Will Instil Bio Inc. stock benefit from green energy trendsMarket Risk Summary & Community Supported Trade Ideas - Улправда
Portfolio Update: Is Instil Bio Inc. stock a good choice for value investorsJuly 2025 Opening Moves & Daily Volume Surge Signals - Улправда
Citizens analyst reiterates Market Perform rating on Instil Bio stock By Investing.com - Investing.com South Africa
Why analysts remain bullish on Instil Bio Inc. stockMarket Entry Points & Low Risk Trading Portfolio - Улправда
Instil Bio (TIL) Downgraded to Neutral by HC Wainwright & Co. | TIL Stock News - GuruFocus
Instil On The Slide After PD-(L)1xVEGF Exit - Citeline News & Insights
Citizens analyst reiterates Market Perform rating on Instil Bio stock - Investing.com
Instil Bio ends license agreement with ImmuneOnco for AXN-2510 and AXN-27M - Investing.com Nigeria
Instil Bio Ends Key Oncology Licensing Agreement with ImmuneOnco - TipRanks
Instil Bio Terminates License and Collaboration Agreement With ImmuneOnco Biopharmaceuticals - TradingView — Track All Markets
Instil Bio shares slide on discontinuation of lead clinical programs - Proactive financial news
Baird downgrades Instil Bio stock to Neutral on AXN-2510 discontinuation By Investing.com - Investing.com South Africa
Baird downgrades Instil Bio stock to Neutral on AXN-2510 discontinuation - Investing.com Canada
Instil Bio Halts Main Drug Development Program - Bitget
US Stocks Mixed; Nasdaq Gains Over 50 Points - Benzinga
Instil's stock sinks after it clears out pipeline, hands 2 drugs back to ImmuneOnco - Fierce Biotech
Instil’s bispecific dream is over | ApexOncoClinical Trials news and analysis - Oncology Pipeline
Instil Bio stock falls after subsidiary discontinues AXN-2510 development By Investing.com - Investing.com Canada
Instil Bio stock falls after subsidiary discontinues AXN-2510 development - Investing.com
Instil Bio’s Subsidiary Discontinues Clinical Development of AXN-2510 and Terminates License and Collaboration Agreement with ImmuneOnco - The Manila Times
Instil Bio’s Subsidiary Discontinues Clinical Development - GlobeNewswire
인스틸 바이오 (TIL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.41%
자본화:
|
볼륨(24시간):